Protective effects of the neuropeptide PACAP in diabetic retinopathy

Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects

(2010) T. Atlasz et al.   Annals of the New York Academy of Sciences

Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy

(2010) Y. Alvarez et al.   Disease Models & Mechanisms

Pigment epithelium derived factor as an anti-inflammatory factor against decrease of glutamine synthetase expression in retinal Müller cells under high glucose conditions

(2010) Xi Shen et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells

(2010) Alessandro Castorina et al.   PEPTIDES

Light regulation of retinal dopamine that is independent of melanopsin phototransduction

(2009) M. A. Cameron et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Suppressors of Cytokine-Signaling Proteins Induce Insulin Resistance in the Retina and Promote Survival of Retinal Cells

(2008) X. Liu et al.   DIABETES

The possible role of retinal dopaminergic system in visual performance

(2007) R. Brandies et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Renoprotection by pituitary adenylate cyclase-activating polypeptide in multiple myeloma and other kidney diseases

(2007) Min Li et al.   REGULATORY PEPTIDES